LY379268 is primarily used in research settings to study its effects on the central nervous system. It acts as a potent agonist for certain glutamate receptors, making it valuable in investigating neurological and psychiatric conditions. Researchers utilize it to explore potential therapeutic applications for disorders such as schizophrenia, anxiety, and addiction. Its ability to modulate glutamate signaling helps in understanding the underlying mechanisms of these conditions. Additionally, it is employed in preclinical studies to assess its neuroprotective properties and its impact on cognitive functions. The compound's selective action on specific receptor subtypes makes it a useful tool for advancing knowledge in neuroscience and drug development.